Unraveling Regulatory Programs for NF-kappaB, p53 and MicroRNAs in Head and Neck Squamous Cell Carcinoma

In head and neck squamous cell carcinoma (HNSCC), mutations of p53 usually coexist with aberrant activation of NF-kappaB (NF-κB), other transcription factors and microRNAs, which promote tumor pathogenesis. However, how these factors and microRNAs interact to globally modulate gene expression and mediate oncogenesis is not fully understood. We devised a novel bioinformatics method to uncover interactive relationships between transcription factors or microRNAs and genes. This approach is based on matrix decomposition modeling under the joint constraints of sparseness and regulator-target connectivity, and able to integrate gene expression profiling and binding data of regulators. We employed this method to infer the gene regulatory networks in HNSCC. We found that the majority of the predicted p53 targets overlapped with those for NF-κB, suggesting that the two transcription factors exert a concerted modulation on regulatory programs in tumor cells. We further investigated the interrelationships of p53 and NF-κB with five additional transcription factors, AP1, CEBPB, EGR1, SP1 and STAT3, and microRNAs mir21 and mir34ac. The resulting gene networks indicate that interactions among NF-κB, p53, and the two miRNAs likely regulate progression of HNSCC. We experimentally validated our findings by determining expression of the predicted NF-κB and p53 target genes by siRNA knock down, and by examining p53 binding activity on promoters of predicted target genes in the tumor cell lines. Our results elucidating the cross-regulations among NF-κB, p53, and microRNAs provide insights into the complex regulatory mechanisms underlying HNSCC, and shows an efficient approach to inferring gene regulatory programs in biological complex systems.

[1]  Brendan J. Frey,et al.  Multi-way clustering of microarray data using probabilistic sparse matrix factorization , 2005, ISMB.

[2]  H. Suemizu,et al.  Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene. , 2012, Experimental and therapeutic medicine.

[3]  C. Watson,et al.  Stat3 and the Inflammation/Acute Phase Response in Involution and Breast Cancer , 2009, Journal of Mammary Gland Biology and Neoplasia.

[4]  X. Sun,et al.  p300/CBP-dependent and -independent transcriptional interference between NF-kappaB RelA and p53. , 2000, Biochemical and biophysical research communications.

[5]  Jay Friedman,et al.  A signal network involving coactivated NF‐κB and STAT3 and altered p53 modulates BAX/BCL‐XL expression and promotes cell survival of head and neck squamous cell carcinomas , 2008, International journal of cancer.

[6]  V. Rotter,et al.  ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promoters. , 2011, Omics : a journal of integrative biology.

[7]  Lorenz Wernisch,et al.  Using Temporal Correlation in Factor Analysis for Reconstructing Transcription Factor Activities , 2008, EURASIP J. Bioinform. Syst. Biol..

[8]  H. Hermeking The miR-34 family in cancer and apoptosis , 2010, Cell Death and Differentiation.

[9]  Paula D. Bos,et al.  Metastasis: from dissemination to organ-specific colonization , 2009, Nature Reviews Cancer.

[10]  Christian J Stoeckert,et al.  Clustering of genes into regulons using integrated modeling-COGRIM , 2007, Genome Biology.

[11]  T. Furey ChIP – seq and beyond : new and improved methodologies to detect and characterize protein – DNA interactions , 2012 .

[12]  Jingxia Li,et al.  Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation. , 2005, Cancer research.

[13]  C. Van Waes,et al.  Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo. , 1999, Cancer research.

[14]  S. Bulun,et al.  Interleukin-1β Elevates Cyclooxygenase-2 Protein Level and Enzyme Activity via Increasing Its mRNA Stability in Human Endometrial Stromal Cells: An Effect Mediated by Extracellularly Regulated Kinases 1 and 2 , 2002 .

[15]  Alberto Inga,et al.  The expanding universe of p53 targets , 2009, Nature Reviews Cancer.

[16]  F. Oakley,et al.  Induction of myofibroblast MMP-9 transcription in three-dimensional collagen I gel cultures: regulation by NF-kappaB, AP-1 and Sp1. , 2004, The international journal of biochemistry & cell biology.

[17]  C. Van Waes,et al.  Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. , 2001, Cancer research.

[18]  G. Dong,et al.  Expression of a Dominant-Negative Mutant Inhibitor-κBα of Nuclear Factor-κB in Human Head and Neck Squamous Cell Carcinoma Inhibits Survival, Proinflammatory Cytokine Expression, and Tumor Growth in Vivo , 1999 .

[19]  Z. Chen Exploration of metastasis-related proteins as biomarkers and therapeutic targets in the treatment of head and neck cancer. , 2007, Current cancer drug targets.

[20]  R. Knight,et al.  TAp63 and DeltaNp63 in cancer and epidermal development. , 2007, Cell cycle.

[21]  Simon C Watkins,et al.  Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Y. Okamoto,et al.  MicroRNAs function as tumor suppressors or oncogenes: aberrant expression of microRNAs in head and neck squamous cell carcinoma. , 2013, Auris, nasus, larynx.

[23]  David Baltimore,et al.  MicroRNAs, new effectors and regulators of NF‐κB , 2012, Immunological reviews.

[24]  C. Van Waes,et al.  CK2 Modulation of NF-κB, TP53, and the Malignant Phenotype in Head and Neck Cancer by Anti-CK2 Oligonucleotides In vitro or In vivo via Sub–50-nm Nanocapsules , 2010, Clinical Cancer Research.

[25]  B. Aggarwal,et al.  NF-κB addiction and its role in cancer: ‘one size does not fit all’ , 2011, Oncogene.

[26]  Olivier Poch,et al.  Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis , 2004, Oncogene.

[27]  A. Elkahloun,et al.  A Novel Nuclear Factor-κB Gene Signature Is Differentially Expressed in Head and Neck Squamous Cell Carcinomas in Association with TP53 Status , 2007, Clinical Cancer Research.

[28]  Sung-Dae Cho,et al.  In vitro apoptotic effects of methanol extracts of Dianthus chinensis and Acalypha australis L. targeting specificity protein 1 in human oral cancer cells , 2013, Head & neck.

[29]  Mathisca C. M. de Gunst,et al.  Identification of context-specific gene regulatory networks with GEMULA - gene expression modeling using LAsso , 2012, Bioinform..

[30]  M. F. Shannon,et al.  Cooperative binding and synergistic activation by RelA and C/EBPbeta on the intercellular adhesion molecule-1 promoter. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[31]  Yu Sun,et al.  The discovery of transcriptional modules by a two-stage matrix decomposition approach , 2007, Bioinform..

[32]  Alice Shapiro,et al.  MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. , 2008, Cancer research.

[33]  Patrik O. Hoyer,et al.  Non-negative Matrix Factorization with Sparseness Constraints , 2004, J. Mach. Learn. Res..

[34]  C. Van Waes,et al.  Deficient TP53 Expression, Function, and Cisplatin Sensitivity Are Restored by Quinacrine in Head and Neck Cancer , 2007, Clinical Cancer Research.

[35]  C. Van Waes,et al.  The Role of the NF-kappaB Transcriptome and Proteome as Biomarkers in Human Head and Neck Squamous Cell Carcinomas. , 2008, Biomarkers in medicine.

[36]  Chiara Sabatti,et al.  Network component analysis: Reconstruction of regulatory signals in biological systems , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Karin NF‐κB and cancer: Mechanisms and targets , 2006 .

[38]  C. Secombes,et al.  Cloning and functional characterisation of the interleukin-1 beta 1 promoter of rainbow trout (Oncorhynchus mykiss). , 2002, Biochimica et biophysica acta.

[39]  R. Knight,et al.  TAp63 and ΔNp63 in Cancer and Epidermal Development , 2007 .

[40]  X. Li,et al.  Cooperative effects of C/EBP-like and NF kappa B-like binding sites on rat serum amyloid A1 gene expression in liver cells. , 1992, Nucleic acids research.

[41]  David Sidransky,et al.  Emerging molecular markers of cancer , 2002, Nature Reviews Cancer.

[42]  M. Karin NF-kappaB and cancer: mechanisms and targets. , 2006, Molecular carcinogenesis.

[43]  D. Chalbos,et al.  Mechanisms underlying differential expression of interleukin-8 in breast cancer cells , 2004, Oncogene.

[44]  C. Van Waes,et al.  TNF-α promotes c-REL/ΔNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer. , 2011, Cancer research.

[45]  George A. Calin,et al.  MicroRNAs — the micro steering wheel of tumour metastases , 2009, Nature Reviews Cancer.

[46]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[47]  A. Bader miR-34 – a microRNA replacement therapy is headed to the clinic , 2012, Front. Gene..

[48]  John J Dunn,et al.  Distinct p53 genomic binding patterns in normal and cancer-derived human cells , 2011, Cell cycle.

[49]  Michael Karin,et al.  Is NF-κB a good target for cancer therapy? Hopes and pitfalls , 2009, Nature Reviews Drug Discovery.

[50]  C. Van Waes,et al.  Constitutive activation of transcription factors NF‐κB, AP‐1, and NF‐IL6 in human head and neck squamous cell carcinoma cell lines that express pro‐inflammatory and pro‐angiogenic cytokines , 1999, Molecular carcinogenesis.

[51]  P. Libby,et al.  Induction of Tissue Factor Expression in Human Endothelial Cells by CD40 Ligand Is Mediated via Activator Protein 1, Nuclear Factor κB, and Egr-1* , 2002, The Journal of Biological Chemistry.

[52]  T. Kanda,et al.  Identification and Characterization of CCAAT Enhancer-binding Protein (C/EBP) as a Transcriptional Activator for Epstein-Barr Virus Oncogene Latent Membrane Protein 1* , 2011, The Journal of Biological Chemistry.

[53]  G. Sonenshein,et al.  TAp63 is a transcriptional target of NF‐κB , 2010, Journal of cellular biochemistry.

[54]  C. Van Waes,et al.  ΔNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation. , 2011, Cancer research.

[55]  M. Karin,et al.  Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. , 2009 .

[56]  Tongbin Li,et al.  miRecords: an integrated resource for microRNA–target interactions , 2008, Nucleic Acids Res..

[57]  G. Schneider,et al.  NFκB/p53 crosstalk-a promising new therapeutic target. , 2011, Biochimica et biophysica acta.

[58]  H. Allgayer,et al.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.

[59]  Sunil Singhal,et al.  Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity , 2005, Oncogene.

[60]  A. Luo,et al.  MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1 , 2013, Oncogene.

[61]  C. Van Waes,et al.  Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma. , 2005, Cancer research.

[62]  Christian J Stoeckert,et al.  Systems biology-defined NF-κB regulons, interacting signal pathways and networks are implicated in the malignant phenotype of head and neck cancer cell lines differing in p53 status , 2008, Genome Biology.

[63]  Fabian J. Theis,et al.  Sparse Component Analysis: a New Tool for Data Mining , 2004 .

[64]  Z. Weng,et al.  A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome , 2006, Cell.

[65]  Binhua Tang,et al.  Hierarchical Modularity in ERα Transcriptional Network Is Associated with Distinct Functions and Implicates Clinical Outcomes , 2012, Scientific Reports.

[66]  M. Rasmussen,et al.  IL-8 and p53 are inversely regulated through JNK, p38 and NF-κB p65 in HepG2 cells during an inflammatory response , 2008, Inflammation Research.

[67]  C. Van Waes,et al.  Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF‐κB and AP‐1 activation and IL‐8 and VEGF expression in human head and neck squamous cell carcinoma lines , 2002, International journal of cancer.

[68]  Z Chen,et al.  Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL‐6: a general role for inflammation? , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[69]  Shuomin Zhu,et al.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis , 2008, Cell Research.

[70]  C. Van Waes,et al.  Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-κB and other signal transcription factors in head and neck squamous cell carcinoma , 2007, Genome Biology.

[71]  S. Ghosh,et al.  Shared Principles in NF-κB Signaling , 2008, Cell.

[72]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[73]  C. Corless,et al.  Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma. , 2006, Genes & development.